White House Withdraws Nomination of Heidi Overton to Lead FDA
The White House has pulled the nomination of Heidi Overton, MD, PhD, for FDA commissioner after it became clear she lacked the necessary votes in the Senate.
🧠AI AnalysisPhoto: medpagetoday.com
Key points
- White House withdraws Heidi Overton's nomination for FDA commissioner
- Nominee faced bipartisan scrutiny over childhood vaccine views and scientific independence
- Senate Health Committee Chairman Bill Cassidy withheld crucial support
The administration announced on Tuesday that it has rescinded the nomination of Heidi Overton, MD, PhD, to head the Food and Drug Administration. Overton, a physician and White House domestic policy advisor, was originally nominated in August to bring stability to the agency following a turbulent tenure under the previous commissioner, Marty Makary, MD, MPH. Her path to confirmation stalled as she faced bipartisan skepticism regarding her stance on childhood immunizations and her willingness to maintain scientific independence from political figures.
During a September hearing, Senate Health Committee Chairman Bill Cassidy, MD (R-La.) questioned Overton extensively about her commitment to established vaccine standards, previously describing her support for separating combination shots like the measles, mumps, and rubella vaccine as nearly disqualifying. To secure a favorable committee vote, Overton needed unanimous support from all 12 Republican members alongside the 11 Democratic seats, a threshold she could not reach. Republican lawmakers are currently working to clear pending nominees before control of the Senate shifts in January.
What to know: Opposition to the nomination also arose from figures within the Make America Healthy Again movement, who criticized administration policies related to pesticide litigation. The FDA remains under the acting leadership of Kyle Diamantas while the agency continues to navigate internal departures and restructuring following significant staff reductions. Readers should consult qualified healthcare professionals for medical guidance.
Source medpagetoday.com — medpagetoday.com/washington-watch/fdageneral/123940 ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …